Kimberly Eyer

This study reveals that IBS patients have significantly lower bifidobacteria counts in both fecal and duodenal samples compared to healthy controls. The marked reduction in Bifidobacterium catenulatum levels suggests a critical link to gut dysbiosis, impaired mucosal integrity, and potential contributions to symptom severity in IBS subtypes.

This study reveals that altered microbiota and elevated organic acids in IBS patients correlate with increased symptom severity, poorer quality of life, and heightened negative emotions. The findings suggest that microbial shifts leading to increased acetic and propionic acid production play a critical role in the pathophysiology of IBS.

This study identifies global microbiota signatures in IBS patients, revealing distinct microbial imbalances that differentiate them from healthy controls. Key findings include a 2-fold increase in the Firmicutes/Bacteroidetes ratio, reduced Bifidobacterium and Faecalibacterium populations, and significant shifts in methanogens. These alterations suggest potential diagnostic markers and therapeutic targets for IBS.

This study identifies distinct microbiome signatures in pediatric IBS, revealing unique microbial imbalances linked to disease subtypes.

This study found that while probiotics may relieve IBS symptoms, they do not revert the gut microbiota imbalances associated with the disorder.

IBS-like symptoms in Parkinson’s disease are linked to distinct gut microbiota changes, particularly Prevotella depletion, implicating the microbiota-gut-brain axis in non-motor symptoms.

This study explores gut microbiome signatures across IBS subtypes, highlighting distinct microbial and metabolic shifts. Findings reveal subtype-specific dysbiosis, with implications for personalized dietary interventions and microbiome-targeted therapies for IBS-D, IBS-C, and IBS-U patients.

This study examines the role of the vaginal microbiome in distinguishing chronic pelvic pain caused by endometriosis and adenomyosis. Findings highlight specific microbial signatures associated with pain severity, offering potential non-invasive biomarkers for differential diagnosis and targeted therapeutic strategies.

Müllerianosis theory posits that embryonic Müllerian duct remnants misplace and differentiate, forming endometrial-like tissues in non-uterine locations post-puberty, contributing to conditions like endometriosis.